نتایج جستجو برای: tp53 mutation and expression

تعداد نتایج: 16973495  

2016
Rashid Saif Ali Raza Awan Leslie Lyons Barbara Gandolfi Muhammad Tayyab Masroor Ellahi Babar Asim Khalid Mehmood Zia Ullah Muhammad Wasim

BACKGROUND Molecular marker based cancer diagnosis gaining more attention in the current genomics era. So, Hspb1 and Tp53 gene characterization and their mRNA expression might be helpful in diagnosis and prognosis of cat mammary adenocarcinoma. It will also add information in comparative cancer genetics and genomics. OBJECTIVES Eight tumors of Siamese cats were analyzed to ascertain germ-line...

2005
Paul C. Turner Abdoulaye Sylla Shuang-Yuan Kuang Clare L. Marchant Mamadou S. Diallo Andrew J. Hall John D. Groopman Christopher P. Wild

Infection with hepatitis viruses and chronic exposure to high levels of dietary aflatoxins are the major etiologic agents for hepatocellular carcinoma in west Africa. A challenge for the prevention of hepatocellular carcinoma in this region is that both hepatitis B virus and aflatoxin exposures start early in life; indeed, aflatoxin exposures can start in utero and continue unabated throughout ...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2012
Karolina Edlund Ola Larsson Adam Ameur Ignas Bunikis Ulf Gyllensten Bernard Leroy Magnus Sundström Patrick Micke Johan Botling Thierry Soussi

Cancer mutation databases are expected to play central roles in personalized medicine by providing targets for drug development and biomarkers to tailor treatments to each patient. The accuracy of reported mutations is a critical issue that is commonly overlooked, which leads to mutation databases that include a sizable number of spurious mutations, either sequencing errors or passenger mutatio...

2013
Enric Domingo Rajarajan Ramamoorthy Dahmane Oukrif Daniel Rosmarin Michal Presz Haitao Wang Hannah Pulker Helen Lockstone Tarjei Hveem Treena Cranston Havard Danielsen Marco Novelli Brian Davidson Zheng-Zhou Xu Peter Molloy Elaine Johnstone Christopher Holmes Rachel Midgley David Kerr Oliver Sieber Ian Tomlinson

Molecular classification of colorectal cancer (CRC) is currently based on microsatellite instability (MSI), KRAS or BRAF mutation and, occasionally, chromosomal instability (CIN). Whilst useful, these categories may not fully represent the underlying molecular subgroups. We screened 906 stage II/III CRCs from the VICTOR clinical trial for somatic mutations. Multivariate analyses (logistic regre...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2002
Aurelia Peraud Friedrich W Kreth Otmar D Wiestler Paul Kleihues Hans-Jürgen Reulen

PURPOSE The purpose of this study was to analyze retrospectively timing, frequency, and prognostic impact of TP53 mutations and P53 protein accumulation in supratentorial WHO grade II astrocytomas and oligoastrocytomas of adult patients. EXPERIMENTAL DESIGN We included 159 consecutively treated patients (1991-1998), and each tumor was screened for TP53 mutations and P53 protein overexpression...

Journal: :Cancer research 2006
Yu-Jen Chen Vicky Hakin-Smith Mario Teo George E Xinarianos David A Jellinek Thomas Carroll David McDowell Martin R MacFarlane Ronald Boet Bruce C Baguley Antony W Braithwaite Roger R Reddel Janice A Royds

The molecular basis for alternative lengthening of telomeres (ALT), a prognostic marker for glioma patients, remains unknown. We examined TP53 status in relation to telomere maintenance mechanism (TMM) in 108 patients with glioblastoma multiforme and two patients with anaplastic astrocytoma from New Zealand and United Kingdom. Tumor samples were analyzed with respect to telomerase activity, tel...

Journal: :Haematologica 2013
Alan H Shih Stephen S Chung Emily K Dolezal Su-Jiang Zhang Omar I Abdel-Wahab Christopher Y Park Stephen D Nimer Ross L Levine Virginia M Klimek

Therapy-related myelodysplastic syndromes and acute myelogenous leukemia comprise a poor-risk subset of myelodysplastic syndromes and acute myelogenous leukemia. Large-scale mutation profiling efforts in de novo myelodysplastic syndromes have identified mutations that correlate with clinical features, but such mutations have not been investigated in therapy-related myelodysplastic syndromes and...

Journal: :Blood 2010
Clive S Zent

There has been considerable progress in analyzing p53 pathway integrity in CLL. Routine fluorescent in situ hybridization (FISH) analysis detects deletion of the region of chromosome 17 (17p13 ), which includes the gene (TP53) coding for p53. 17p13 is a powerful predictor of resistance to therapy with purine analogues and alkylating agents and poor prognosis in CLL. Approximately 80% of CLL pat...

Journal: :International journal of clinical and experimental pathology 2014
Britta Kleist Marcel Kempa Michael Novy Christian Oberkanins Li Xu Guojun Li Christiane Loland Micaela Poetsch

Neuroendocrine differentiation of tumor tissue has been recognized as an important prerequisite for new targeted therapies. To evaluate the suitability of colorectal cancer (CRC) tissue for these treatment approaches and to find a possible link to pretherapeutic conditions of other targeted strategies, we compared neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutational status i...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2002
Ming-Lan Lu Friedrik Wikman Torben F Orntoft Elizabeth Charytonowicz Farhang Rabbani Zuofeng Zhang Guido Dalbagni Kamal S Pohar Guopei Yu Carlos Cordon-Cardo

This study was designed to define the potential clinical relevance of identifying alterations affecting p53 pathway in bladder cancer and to test a new, low-cost, high-throughput, and array-based TP53 sequencing technology. Tumor samples from 140 evaluable patients with bladder cancer were analyzed with two methods to detect TP53 gene mutations, including single-stranded conformational polymorp...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید